scispace - formally typeset
Search or ask a question
Institution

European Society of Hypertension

OtherMilan, Italy
About: European Society of Hypertension is a other organization based out in Milan, Italy. It is known for research contribution in the topics: Blood pressure & Ambulatory blood pressure. The organization has 146 authors who have published 167 publications receiving 20150 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The value of beta blockers and the double blockade of the renin-angiotensin-aldosterone system are under discussion and the interpretation of corresponding studies must be conducted very carefully.
Abstract: Die medikamentose antihypertensive Therapie ist auf allen Ebenen der Pravention eine der erfolgreichsten medizinischen Masnahmen uberhaupt. In Deutschland hat sich die Behandlungssituation in den letzten Jahren deutlich verbessert. Heute steht uns eine breite Palette gut wirksamer und gut vertraglicher antihypertensiver Substanzen zur Verfugung. Die Kombinationstherapie hat in der Hypertoniebehandlung eine lange und erfolgreiche Tradition, insbesondere mit sinnvollen fixen Kombinationen. Die Verwendung von fixen Kombinationen ist daruber hinaus der Therapieadharenz sehr forderlich, denn diese hangt ganz wesentlich von der Anzahl der einzunehmenden Medikamente ab. Zur Diskussion stehen der Stellenwert der β-Blocker und die doppelte Blockade des Renin-Angiotensin-Aldosteron-Systems. Hier muss die Interpretation der entsprechenden Studien sehr sorgfaltig betrieben werden. Die blutdrucksenkende Wirkung einer Substanz kann ohne Berucksichtigung der Tageszeit, des Messzeitpunkts und des Zeitpunkts der Einnahme nicht umfassend beurteilt werden. Dies ist besonders wichtig mit Blick auf die 24-h-Wirkung. Ebenso muss eine optimale antihypertensive Therapie hinsichtlich der Dosis und Dosierungsintervalle den individuellen Blutdruckrhythmus uber die Zeit berucksichtigen. Die Bedeutung des zentralen (aortalen) Blutdrucks als Zielblutdruck wird zunehmen.

4 citations

Journal ArticleDOI
TL;DR: The CALM-FIM_EUR study is a first-in-human, proof-of-principle, open-label trial testing the safety and blood-pressure efficacy of a new interventional strategy to stimulate the endovascular baroreflex, and a passive stentlike device that is implanted in the carotid artery to reshape theCarotid sinus and reduce sympathetic outflow is used.

4 citations

Journal ArticleDOI
TL;DR: The case of a 64-year-old man with both severe aortic stenosis and cirrhosis who was first managed by TAVR and then underwent liver transplantation is reported.
Abstract: Transcatheter aortic valve replacement (TAVR) indications are rapidly increasing. We report here the case of a 64-year-old man with both severe aortic stenosis and cirrhosis. He was first managed by TAVR and then underwent liver transplantation. Two and one-half years later, he was admitted for

4 citations

Journal ArticleDOI
TL;DR: Evidence draws attention to the fact that vascular stiffness precedes the increase in blood pressure with age and that even nonpharmacological lifestyle interventions can improve distensibility independent of blood pressure.
Abstract: Arterial pulse-wave velocity is a noninvasive index of arterial distensibility now generally advocated to assess cardiovascular health above-and-beyond merely measuring blood pressure. A host of recent findings supports its use. This evidence draws attention to the fact that vascular stiffness precedes the increase in blood pressure with age and that even nonpharmacological lifestyle interventions can improve distensibility independent of blood pressure. Where do these ingeniously modern ideas come from, and who defined the principles we embrace today? A worthwhile lesson in physiology and exercise in humility is the effort to revisit the origins of these concepts and the man to whom gratitude should be directed.

4 citations

Journal ArticleDOI
TL;DR: The conclusions of this interesting study support the concept that the MetS, regardless of the criteria used to define it (NCEP-ATPIII or IDF), may be considered, at least in part, as a potentially reversible prohypertensive state.

4 citations


Authors

Showing all 146 results

NameH-indexPapersCitations
Suzanne Oparil106885113983
Sverre E. Kjeldsen9473589059
Josep Redon7748881395
Eva Prescott7534946067
Renata Cifkova6830580868
Enrico Agabiti Rosei5220027518
Riccardo Sarzani371364724
Giovanni Cerasola321433355
Santina Cottone321483140
Paolo Dessì-Fulgheri31773810
Giuseppe Mulè311522984
Alessandro Rappelli291113112
Emilio Nardi27902130
Federico Guerra241411559
Giampiero Bricca21931592
Network Information
Related Institutions (5)
Vita-Salute San Raffaele University
22.4K papers, 953K citations

83% related

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
15.4K papers, 434.4K citations

83% related

Mario Negri Institute for Pharmacological Research
13.2K papers, 829.1K citations

83% related

New York Medical College
18K papers, 681.8K citations

80% related

Seconda Università degli Studi di Napoli
21.6K papers, 546.7K citations

79% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20219
202022
201915
201813
201711
201625